Mtb-Tox 6 X Liquid is a Health Canada–registered human drug (DIN 02233653) held by Bio Active Canada Ltd., containing Insulin. Health Canada lists its status as Cancelled Post Market (status date 28 Sep 2007). Nexara Health has matched 172 registrations of Insulin across 35 other regulated markets, 1 of them in the same strength and dosage form.
Health Canada registration
| DIN | 02233653 |
|---|---|
| Brand name | Mtb-Tox |
| Active ingredient | Insulin |
| Strength | 6 X |
| Dosage form | Liquid |
| Route | Oral |
| Company | Bio Active Canada Ltd. |
| Status | Cancelled Post Market — 28 Sep 2007 |
| Class | Human |
| ATC | |
| AHFS | 92:02.00* ; See footnote |
| Regulator record | Health Canada DPD entry · Product monograph |
Insulin registered in other markets
172 registrations of the same molecule in 35 national registries outside Canada (first 92 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| United States | Insulin 1556 | Professional Complementary Health Formulas | Liquid | listed | FDA NDC | |
| Argentina | Insulina Apidra Solostar | Sanofi-Aventis | 100UI/ml lap.prellx5x3ml | Listed | PAMI | |
| Australia | Apidra | Av | Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5 | GE | PBS | |
| Australia | Apidra | Sw | Injection (human analogue) 100 units per mL, 10 mL | GE | PBS | |
| Australia | Apidra SoloStar | Sw | Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5 | GE | PBS | |
| Austria | Apidra 100 E/ml Inj.lsg. Dstfl. | — | 1St | green box | eEKO (Erstattungskodex) | |
| Austria | Apidra 100 E/ml Inj.lsg. Fertigpen, SoloStar | — | 5St | green box | eEKO (Erstattungskodex) | |
| Austria | Apidra 100 E/ml Inj.lsg. Patronen | — | 5St | green box | eEKO (Erstattungskodex) | |
| Bahrain | Apidra Solostar | Sanofi-Aventis Deutschland GmbH, Germany. | 100 U/ML | Solution For Injection In Pre-Filled Pen | POM | NHRA |
| Bolivia | Insulina Glulisina | — | 100 U.I/ml | Inyectable | LINAME (formulary) | |
| Brazil | Apidra | Sanofi Medley Farmacêutica Ltda. | 100 UI/ML SOL INJ CT 1 CARP VD INC X 3 ML + 1 SISTEMA APLIC PLAS | Biológico | CMED | |
| Brazil | Apidra | Sanofi Medley Farmacêutica Ltda. | 100 UI/ML SOL INJ CT 1 FA VD INC X 10 ML | Biológico | CMED | |
| Croatia | Apidra | Sanofi-Aventis Deutschland GmbH | otop. za inj., brizg. napunj. SoloStar 5x3 ml (100 U/ml) | R | HZZO | |
| Czech Republic | Apidra | — | 100U/ML | Inj Sol Via | R | SUKL DLP |
| Czech Republic | Apidra | — | 100U/ML | Inj Sol Via | R | SUKL DLP |
| Czech Republic | Apidra | — | 100U/ML | Inj Sol Via | R | SUKL DLP |
| Czech Republic | Apidra | — | 100U/ML | Inj Sol Zvl | R | SUKL DLP |
| Czech Republic | Apidra | — | 100U/ML | Inj Sol Zvl | R | SUKL DLP |
| Czech Republic | Apidra | — | 100U/ML | Inj Sol Zvl | R | SUKL DLP |
| Czech Republic | Apidra | — | 100U/ML | Inj Sol Zvl | R | SUKL DLP |
| Czech Republic | Apidra | — | 100U/ML | Inj Sol Via | R | SUKL DLP |
| Denmark | Apidra | Sanofi-Aventis Deutschland GmbH | 100 Enheder/ml | injektionsvæske, opløsning i cylinderampul | Central | Laegemiddelstyrelsen |
| Denmark | Apidra | Sanofi-Aventis Deutschland GmbH | 100 Enheder/ml | injektionsvæske, opløsning | Central | Laegemiddelstyrelsen |
| Denmark | Apidra SoloStar | Sanofi-Aventis Deutschland GmbH | 100 Enheder/ml | injektionsvæske, opløsning i fyldt pen | Central | Laegemiddelstyrelsen |
| Dominican Republic | Apidra | Sanofi -Aventis Deutschland GmbH | Registered | MISPAS | ||
| European Union (EMA) | Apidra | sanofi-aventis Deutschland GmbH | Authorised | EMA centrally authorised | ||
| Finland | Apidra | Sanofi-Aventis Deutschland GmbH | 100 U/ml | injektioneste, liuos | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Finland | Apidra | Sanofi-Aventis Deutschland GmbH | 100 U/ml | injektioneste, liuos, sylinteriampulli | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Finland | Apidra Solostar | Paranova Oy | 100 U/ml | injektioneste, liuos, esitäytetty kynä | Myyntilupa peruuntunut | Fimea Perusrekisteri |
| Finland | Apidra Solostar | Sanofi-Aventis Deutschland GmbH | 100 U/ml | injektioneste, liuos, esitäytetty kynä | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Greece | ABASAGLAR INJ.SOL 100U/ML 2 BTx5 PF.PEN x3ML (kwikPen, συσκευή χορήγησης από 1 έως 80 μονάδες) - πολυσυσκευασία | Eli Lilly Nederland B.v., The Nederlands | reimbursed | MoH deltio timwn | ||
| Greece | ABASAGLAR INJ.SOL 100U/ML BTx10 CARTRIDGES x 3ML | Eli Lilly Nederland B.v., The Nederlands | reimbursed | MoH deltio timwn | ||
| Greece | ABASAGLAR INJ.SOL 100U/ML BTx5 PF.PEN x3ML (kwikPen, συσκευή χορήγησης από 1 έως 80 μονάδες) | Eli Lilly Nederland B.v., The Nederlands | reimbursed | MoH deltio timwn | ||
| Greece | Actrapid - 100 IU/mL Inj.sol 100iu/mL 1γυαλ.φιαλ.χ10ml | Novo Nordisk A/S, Bagsvaerd, Denmark | reimbursed | MoH deltio timwn | ||
| Greece | Actrapid Penfill 100 IU/mL Inj.sol 100 IU/mL 5γυαλ.φιαλ.χ3ml | Novo Nordisk A/S, Bagsvaerd, Denmark | reimbursed | MoH deltio timwn | ||
| Greece | APIDRA INJ.SOL 100 IU/ML BT x 3 PF PEN (SOLO STAR) x 3 ML (SOLO STAR) x 3 ML | Sanofi-Aventis Deutschland GmbH, Frankfurt Am Main, Germany | reimbursed | MoH deltio timwn | ||
| Greece | APIDRA INJ.SOL 100 U/ML 1 VIAL x 10 ML (ΦΙΑΛΙΔΙΟ ΓΥΑΛΙΝΟ) (ΦΙΑΛΙΔΙΟ ΓΥΑΛΙΝΟ) | Sanofi-Aventis Deutschland GmbH, Frankfurt Am Main, Germany | reimbursed | MoH deltio timwn | ||
| Greece | APIDRA INJ.SOL 100 U/ML 5 CARTRIDGESx 3 ML (ΦΥΣΙΓΓΙΑ ΓΥΑΛΙΝΑ) (ΦΥΣΙΓΓΙΑ ΓΥΑΛΙΝΑ) | Sanofi-Aventis Deutschland GmbH, Frankfurt Am Main, Germany | reimbursed | MoH deltio timwn | ||
| Hong Kong | Apidra Solostar Solution For Inj 100 Units/mL (Pre-Filled Pen) | Sanofi Hong Kong Limited | Registered | DH Drug Office | ||
| Hungary | Apidra 100 Egység/mL Oldatos Injekció Előretöltött Injekciós Tollban (Solostar) | Sanofi-Aventis Pharma Deutschland GmbH | 5x3ml előretöltött injekciós tollban | NEAK PUPHA | ||
| Hungary | Apidra 100 Egység/mL Oldatos Injekció Patronban | Sanofi-Aventis Pharma Deutschland GmbH | 5x3ml | NEAK PUPHA | ||
| Iceland | Apidra | Distica - óskráð lyf | 100 ein/ml | stl | 0 | Lyfjastofnun lyfjaverdskra |
| Ireland | Apidra 100 Units/ml Solution for injection | Sanofi-Aventis Deutschland GmbH | Solution for injection | Unknown | HPRA | |
| Ireland | Apidra 100 Units/ml Solution for injection | Aventis Pharma Deutschland GmbH | Solution for injection | Unknown | HPRA | |
| Italy | APIDRA*1 flaconcino SC 10 ml 100 U/ml | Sanofi Aventis Deutschl.gmbh | INSULINA GLULISINA 1.000U 10ML 1 UNITA' USO PARENTERALE | Classe A | AIFA liste A/H | |
| Italy | APIDRA*5 cartucce SC 3 ml 300 U | Sanofi Aventis Deutschl.gmbh | INSULINA GLULISINA 300U 3ML 5 UNITA' USO PARENTERALE | Classe A | AIFA liste A/H | |
| Italy | APIDRA*solostar 5 penne preriempite SC 100 U/ml 3 ml | Sanofi Aventis Deutschl.gmbh | INSULINA GLULISINA 300U 3ML 5 UNITA' USO PARENTERALE | Classe A | AIFA liste A/H | |
| Luxembourg | APIDRA SOL.INJ. 100 UI / 1 mL 1*1 FL.VERRE 10 ML | — | R | CNS liste positive | ||
| Luxembourg | APIDRA SOL.INJ. 100 UI / 1 mL 1*5 CARTOUCHES VERRE 3 ML | — | R | CNS liste positive | ||
| Luxembourg | APIDRA SOL.INJ. 100 UI / 1 mL 1*5 STYLOS SOLOSTAR 3 ML | — | R | CNS liste positive | ||
| Mexico | Insulina Glulisina | — | Grupo Nº 5: Endocrinología y Metabolismo | CSG Compendio (formulary) | ||
| Netherlands | Apidra 100 Eenheden/ml oplossing voor injectie in patroon | Sanofi-Aventis Deutschland GmbH | Oplossing voor injectie | Uitsluitend recept | EU national register | |
| Norway | Insulin glulisin SA inj, oppl 100 E/ml | Sykehusapoteket Oslo, Ullevål | 10 x 3.15 | Injeksjonsvæske, oppløsning | Aktiv oppføring | FEST (DMP) |
| Poland | Apidra | Sanofi-Aventis Deutschland GmbH | 100 j.m./ml | Roztwór do wstrzykiwań we wkładzie | URPL RPL | |
| Poland | Apidra | Sanofi-Aventis Deutschland GmbH | 100 j.m./ml | Roztwór do wstrzykiwań | URPL RPL | |
| Poland | Apidra SoloStar | Sanofi-Aventis Deutschland GmbH | 100 j.m./ml | Roztwór do wstrzykiwań we wstrzykiwaczu | URPL RPL | |
| Romania | APIDRA 100U/ml | — | 100U/ml | Sol. Inj. In Cartus | P-RF | ANMDMR nomenclator |
| Romania | APIDRA 100U/ml | — | 100U/ml | Sol. Inj. In Cartus | P-RF | ANMDMR nomenclator |
| Romania | APIDRA 100U/ml | — | 100U/ml | Sol. Inj. In Cartus | P-RF | ANMDMR nomenclator |
| Romania | APIDRA 100U/ml | — | 100U/ml | Sol. Inj. In Cartus | P-RF | ANMDMR nomenclator |
| Romania | APIDRA 100U/ml | — | 100U/ml | Sol. Inj. In Cartus | P-RF | ANMDMR nomenclator |
| Romania | APIDRA 100U/ml | — | 100U/ml | Sol. Inj. In Cartus | P-RF | ANMDMR nomenclator |
| Romania | APIDRA 100U/ml | — | 100U/ml | Sol. Inj. In Cartus | P-RF | ANMDMR nomenclator |
| Romania | APIDRA 100U/ml | — | 100U/ml | Sol. Inj. In Cartus | P-RF | ANMDMR nomenclator |
| Saudi Arabia | APIDRA 100 U- ML Injection* | — | 100 | Inactive | SFDA | |
| Saudi Arabia | Apidra Solostar 100 U- mL Disposable Pen | — | 100 | Inactive | SFDA | |
| Serbia | Apidra® Solostar® | Amicus Srb D.o.o. | OBNOVA | ALIMS | ||
| Singapore | Apidra SoloStar 100 Units/ml Solution for injection in a pre-filled pen | Sanofi-Aventis Singapore Pte. Ltd. | 3.49 mg (100 Units) | Injection, Solution | Prescription Only | HSA |
| Slovakia | Apidra SoloStar 100 jednotiek/ml injekčný roztok v naplnenom pere | Sav-D | sol inj 5x3 ml (100 IU/ ml) (napl. pero- sklo- SoloStar) | O | MZ SR kategorizacia | |
| Slovenia | Apidra SoloStar 100 i.e./ml razt.za inj. peresnik Solo Star 3 ml 5x | — | P | CBZ | ||
| South Africa | Actrapid HM (ge) | Novo Nordisk (Pty) Ltd | 100 u/ml | Inj | S3 | DoH SEP database |
| South Africa | Actrapid HM (ge) | Novo Nordisk (Pty) Ltd | 100 u/ml | Ped | S3 | DoH SEP database |
| South Africa | Apidra | Sanofi Aventis South Africa (Pty) Ltd | 100 IU/ml | Sus | S4 | DoH SEP database |
| South Africa | Apidra | Sanofi Aventis South Africa (Pty) Ltd | 100 IU/ml | Cat | S4 | DoH SEP database |
| South Africa | Apidra | Sanofi Aventis South Africa (Pty) Ltd | 100 IU/ml | Ped | S4 | DoH SEP database |
| South Africa | Apidra | Sanofi Aventis South Africa (Pty) Ltd | 100 IU/3ml | Inj | Discontinued | DoH SEP database |
| Taiwan | D.s. Insulin 40iu | Dong Shin Pharm Co. Ltd. | 注射劑 | 已註銷 | TFDA | |
| Taiwan | D.s. Insulin 40iu | Dong Shin Pharm Co. Ltd. | 注射劑 | 已註銷 | TFDA | |
| Taiwan | D.s. Insulin 80i.u. | Dong Shin Pharm Co. Ltd. | 注射劑 | 已註銷 | TFDA | |
| Taiwan | D.s. Insulin 80iu | Dong Shin Pharm Co. Ltd. | 注射劑 | 已註銷 | TFDA | |
| Taiwan | Insulin | N.v. Organon | 注射劑 | 已註銷 | TFDA | |
| Taiwan | Insulin | Dr. Christian Brunnengraber | 注射劑 | 已註銷 | TFDA | |
| Taiwan | Insulin | N.v. Organon | 注射劑 | 已註銷 | TFDA | |
| Taiwan | Insulin Injection (Fiselin) | Torii Pharmaceutical Co.,Ltd. | 注射劑 | 已註銷 | TFDA | |
| Turkey | Apidra 100 U/mL Solostar Sc Kullanim Icin Enjeksiyonluk Cozelti(5 Enjeksiyon Kalemi) | Sanofi̇ Sağlik Ürünleri̇ Ltd. Şti̇. | Aktif | TITCK | ||
| United Arab Emirates | Apidra® SoloStar® | SANOFI-AVENTIS DEUTSCHLANDGmbH, Germany, Frankfurt am Main | 100 Units/ml | Injection | Active | EDE |
| United Kingdom | Insulin glulisine 100units/ml solution for injection 10ml vials | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Insulin glulisine 100units/ml solution for injection 3ml cartridges | — | 0009 | NHS dm+d VMP | ||
| United Kingdom | Insulin glulisine 100units/ml solution for injection 3ml pre-filled disposable devices | — | 0009 | NHS dm+d VMP | ||
| United States | Apidra | sanofi-aventis U.S. LLC | Injection, Solution | listed | FDA NDC | |
| United States | Apidra SoloStar | sanofi-aventis U.S. LLC | Injection, Solution | listed | FDA NDC | |
| United States | Insulin | Biocon Biologics Limited | Powder | FDA NDC |
See every manufacturer of Insulin worldwide →
Regulator price references for Insulin
Published list or reimbursement prices for Insulin presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| Australia | Apidra | Injection (human analogue) 100 units per mL, 10 mL | 16.33 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Apidra SoloStar | Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5 | 28.19 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Apidra | Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5 | 28.19 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Austria | Apidra 100 E/ml Inj.lsg. Dstfl. | 1St | 27.70 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 | |
| Austria | Apidra 100 E/ml Inj.lsg. Patronen | 5St | 40.30 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 | |
| Austria | Apidra 100 E/ml Inj.lsg. Fertigpen, SoloStar | 5St | 42.00 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 | |
| Bahrain | Apidra Solostar | 100u/1ml | 5 X 3ML | 18.14 BHD | retail (max) | NHRA | 2026-09-01 |
| Brazil | Apidra | 3ml | 100 UI/ML SOL INJ CT 1 CARP VD INC X 3 ML + 1 SISTEMA APLIC PLAS | 29.15 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Apidra | 10ml | 100 UI/ML SOL INJ CT 1 FA VD INC X 10 ML | 97.13 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Greece | Actrapid - 100 IU/mL Inj.sol 100iu/mL 1γυαλ.φιαλ.χ10ml | 100iu/1ml+100iu/1ml | 8.33 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | Protaphane-100 IU/mL Inj.susp 100 IU/mL Btx1vialx10ml | 100iu/1ml+100iu/1ml | 8.36 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | HUMULIN REGULAR INJ.SOL 100IU/ML BTx1 VIAL x 10 ML | 100iu/1ml | 9.88 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | HUMULIN NPH INJ.SUSP 100IU/ML BTx1 VIAL x 10 ML | 100iu/1ml | 9.90 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | Novorapid Inj.sol 100u/mL 1vialx10ml | 100u/1ml | 11.52 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | FIASP INJ.SOL 100U/ML 1 VIAL (γυαλί ) x 10ML | 100u/1ml | 11.81 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | APIDRA INJ.SOL 100 U/ML 1 VIAL x 10 ML (ΦΙΑΛΙΔΙΟ ΓΥΑΛΙΝΟ) (ΦΙΑΛΙΔΙΟ ΓΥΑΛΙΝΟ) | 100u/1ml | 12.17 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | LYUMJEV INJ.SOL 100IU/ML 1 VIALx10 ml (3.5 MG/ML) | 100iu/1ml+3.5mg/1ml | 13.16 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | Humalog Inj.sol 100 U/mL Btx1vialx10ml | 100u/1ml | 14.09 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | HUMULIN(REGULAR)CARTRIDGE INJ.SOL 100 IU/ML BTx5CARTRx3ML για χρηση σε συνδυασμό με συστήματα χορήγησης ινσουλίνης τύπου πένας φέροντα σήμανση CE | 100iu/1ml | 16.32 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | APIDRA INJ.SOL 100 IU/ML BT x 3 PF PEN (SOLO STAR) x 3 ML (SOLO STAR) x 3 ML | 100iu/1ml | 16.94 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | Actrapid Penfill 100 IU/mL Inj.sol 100 IU/mL 5γυαλ.φιαλ.χ3ml | 100iu/1ml+100iu/1ml | 17.54 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | Protaphane Penfill-100iu/mL Inj.susp 100 IU/mL Btx5φυσιγγιαχ3ml | 100iu/1ml+100iu/1ml | 17.68 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | HUMULIN(NPH)CARTRIDGE INJ.SUSP 100IU/ML BTx5CARTRIDGx3ML για χρηση σε συνδυασμό με συστήματα χορήγησης ινσουλίνης τύπου πένας φέροντα σήμανση CE | 100iu/1ml | 18.51 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | NOVORAPID PENFILL INJ.SOL 100U/ML 5CARTRIDGESx3ML | 100u/1ml | 18.88 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | Novorapid Flex Pen Inj.sol 100 U/mL 5pf.syr.x3ml | 100u/1ml | 20.09 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | FIASP INJ.SOL 100U/ML 5 Φυσίγγια (γυαλί) - (Penfill) x 3ML | 100u/1ml | 20.20 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | APIDRA INJ.SOL 100 U/ML 5 CARTRIDGESx 3 ML (ΦΥΣΙΓΓΙΑ ΓΥΑΛΙΝΑ) (ΦΥΣΙΓΓΙΑ ΓΥΑΛΙΝΑ) | 100u/1ml | 20.82 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | Humalog-Cartridge Inj.sol 100 U/mL Btx5 Cartr.x3ml | 100u/1ml | 21.96 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | Lantus Inj.sol 100 IU/mL Vial 5ml 1υαλινο Vial X10ml | 100iu/1ml | 22.28 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | HUMALOG-MIX 25 CARTRIDGE INJ.SUSP 100 U/ML CARTR.3ML BTx5ΦΥΣΙΓΓΙΑ/CARTR. HUMALOG MIX25 x 3 ML HUMALOG MIX25 X 3 ML | 100u/1ml | 22.61 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | HUMALOG-MIX 50 CARTRIDGE INJ.SUSP 100 U/ML CARTR.3ML BTx 5 ΦΥΣΙΓΓΙΑ/CARTR. HUMALOG MIX50 x 3ML HUMALOG MIX50 X 3ML | 100u/1ml | 22.61 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | FIASP INJ.SOL 100U/ML 5 PF.PEN (γυαλί - Flex-Touch) x 3ML | 100u/1ml | 23.16 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | HUMALOG JUNIOR KWIKPEN INJ.SOL 100 U/ML BTx5 PF.PEN x3ML (3,5mg/ML) | 100u/1ml+3.5mg/1ml | 25.24 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | HUMALOG (MIX 25 KWIKPEN) INJ.SUSP 100 U/ML BTx 5 PF PEN x 3ML (3,5MG/ML) (3,5MG/ML) | 100u/1ml+3.5mg/1ml+3.5mg/1ml | 25.80 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | HUMALOG (MIX 50 KWIKPEN) INJ.SUSP 100 U/ML BTx 5 PF PEN x 3ML (3,5MG/ML) (3,5MG/ML) | 100u/1ml+3.5mg/1ml+3.5mg/1ml | 25.81 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | HUMALOG (KWIKPEN) INJ.SOL 100 IU/ML BTx 5 PF PEN x 3ML (3,5MG/ML) (3,5MG/ML) | 100iu/1ml+3.5mg/1ml+3.5mg/1ml | 26.31 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | LYUMJEV INJ.SOL 100IU/ML 5 προγεμισμένες συσκευές τύπου πένας x3 ml (3.5 MG/ML) - Kwik pen | 100iu/1ml+3.5mg/1ml | 26.58 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | LYUMJEV INJ.SOL 100IU/ML 5 προγεμισμένες συσκευές τύπου πένας x3 ml (3.5 MG/ML) - junior Kwik pen | 100iu/1ml+3.5mg/1ml | 26.58 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | LANTUS INJ.SOL 100 IU/ML BTx3 PF PEN (SOLO STAR) x 3 ML (SOLO STAR) x 3 ML | 100iu/1ml | 27.31 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | TOUJEO IN.SO.PF.P 300 Units/ml BTx3 PF.PENS (Solostar) x1,5ml | 1.5ml | 30.23 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | ABASAGLAR INJ.SOL 100U/ML BTx5 PF.PEN x3ML (kwikPen, συσκευή χορήγησης από 1 έως 80 μονάδες) | 100u/1ml | 31.55 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | Lantus Inj.sol 100 IU/mL Cartr.3ml Btx5cartr.x3ml | 100iu/1ml | 32.49 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | LEVEMIR INJ.SOL 100 U/ml PENFILL 5 CART X 3 ML | 100u/1ml | 38.67 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | LEVEMIR IN.SO.PF.P 100 U/ml FLEXPEN 5 PF.PEN X 3 ML | 100u/1ml | 38.67 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | TRESIBA INJ.SOL 100U/ML 5 PF.PEN - γυαλί (Flex Touch) x 3ML | 100u/1ml | 43.75 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | HUMALOG KWIKPEN INJ.SOL 200 U/ML BTx5 PF.PEN x3ML (6,9mg/ML) | 200u/1ml+6.9mg/1ml | 50.44 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | TOUJEO IN.SO.PF.P 300 Units/ml 3 PF.PENS (Double Star) x3ml | 3ml | 59.90 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | ABASAGLAR INJ.SOL 100U/ML 2 BTx5 PF.PEN x3ML (kwikPen, συσκευή χορήγησης από 1 έως 80 μονάδες) - πολυσυσκευασία | 100u/1ml | 70.17 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | ABASAGLAR INJ.SOL 100U/ML BTx10 CARTRIDGES x 3ML | 100u/1ml | 72.02 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | LANTUS INJ.SOL 100 IU/ML BTx10 PF PEN (SOLO STAR) x 3 ML (SOLO STAR) x 3 ML | 100iu/1ml | 72.68 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Hungary | Apidra 100 Egység/mL Oldatos Injekció Patronban | 3ml | 5x3ml | 7,009.00 HUF | producer price (ex-factory) | NEAK PUPHA | 2026-09-03 |
| Hungary | Apidra 100 Egység/mL Oldatos Injekció Előretöltött Injekciós Tollban (Solostar) | 3ml | 5x3ml előretöltött injekciós tollban | 7,009.00 HUF | producer price (ex-factory) | NEAK PUPHA | 2026-09-03 |
| Iceland | Apidra | hgl | 2,252.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 | |
| Italy | APIDRA*1 flaconcino SC 10 ml 100 U/ml | 10ml+1u | INSULINA GLULISINA 1.000U 10ML 1 UNITA' USO PARENTERALE | 31.28 EUR | prezzo al pubblico (classe A) | AIFA liste A/H | 2026-09-02 |
| Italy | APIDRA*solostar 5 penne preriempite SC 100 U/ml 3 ml | 300u+3ml | INSULINA GLULISINA 300U 3ML 5 UNITA' USO PARENTERALE | 46.92 EUR | prezzo al pubblico (classe A) | AIFA liste A/H | 2026-09-02 |
| Italy | APIDRA*5 cartucce SC 3 ml 300 U | 300u+3ml | INSULINA GLULISINA 300U 3ML 5 UNITA' USO PARENTERALE | 46.92 EUR | prezzo al pubblico (classe A) | AIFA liste A/H | 2026-09-02 |
| Luxembourg | APIDRA SOL.INJ. 100 UI / 1 mL 1*1 FL.VERRE 10 ML | 10ml+1ml | 23.72 EUR | reimbursement | CNS liste positive | 2026-09-05 | |
| Luxembourg | APIDRA SOL.INJ. 100 UI / 1 mL 1*5 CARTOUCHES VERRE 3 ML | 1ml+3ml | 35.30 EUR | reimbursement | CNS liste positive | 2026-09-05 | |
| Luxembourg | APIDRA SOL.INJ. 100 UI / 1 mL 1*5 STYLOS SOLOSTAR 3 ML | 1ml+3ml | 39.35 EUR | reimbursement | CNS liste positive | 2026-09-05 | |
| Saudi Arabia | APIDRA 100 U- ML Injection* | 100u | 146.45 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Apidra Solostar 100 U- mL Disposable Pen | 100u | 169.10 SAR | public | SFDA | 2026-09-01 | |
| Slovakia | Apidra SoloStar 100 jednotiek/ml injekčný roztok v naplnenom pere | 100iu/1ml | sol inj 5x3 ml (100 IU/ ml) (napl. pero- sklo- SoloStar) | 25.29 EUR | categorised final price | MZ SR kategorizacia | 2026-09-02 |
| South Africa | Actrapid HM (ge) | 100u/1ml | 10 | 305.00 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Apidra | 100iu/3ml | 3 | 372.32 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Apidra | 100iu/1ml | 3 | 419.62 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Apidra | 100iu/1ml | 10 | 459.34 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Actrapid HM (ge) | 100u/1ml | 3 | 565.96 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Apidra | 100iu/1ml | 3 | 625.05 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| United Arab Emirates | Apidra® SoloStar® | 5's (3ml Pre-filled Pen x 5) | 184.50 AED | public | EDE | 2026-08-31 |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Mtb-Tox (DIN 02233653) marketed in Canada?
No. Health Canada lists DIN 02233653 as Cancelled Post Market as of 28 Sep 2007.
Who holds the Canadian licence for this product?
Bio Active Canada Ltd. is the company of record in the Health Canada Drug Product Database.
Is Insulin registered outside Canada?
Yes — Nexara Health has matched 172 registrations in 35 other markets, including 1 in the same strength and dosage form (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02233653, status date 2007-09-28; national medicine registries: AIFA liste A/H, ALIMS, ANMDMR nomenclator, CBZ, CMED, CNS liste positive, CSG Compendio (formulary), DH Drug Office, DoH SEP database, EDE, eEKO (Erstattungskodex), EMA centrally authorised, EU national register, FDA NDC, FEST (DMP), Fimea Perusrekisteri, HPRA, HSA, HZZO, Laegemiddelstyrelsen, LINAME (formulary), Lyfjastofnun lyfjaverdskra, MISPAS, MoH deltio timwn, MZ SR kategorizacia, NEAK PUPHA, NHRA, NHS dm+d VMP, PAMI, PBS, SFDA, SUKL DLP, TFDA, TITCK, URPL RPL; price sources: AIFA liste A/H, CMED, CNS liste positive, DoH SEP database, EDE, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, MoH deltio timwn, MZ SR kategorizacia, NEAK PUPHA, NHRA, PBS, SFDA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02233653, status date 2007-09-28; national medicine registries: AIFA liste A/H, ALIMS, ANMDMR nomenclator, CBZ, CMED, CNS liste positive, CSG Compendio (formulary), DH Drug Office, DoH SEP database, EDE, eEKO (Erstattungskodex), EMA centrally authorised, EU national register, FDA NDC, FEST (DMP), Fimea Perusrekisteri, HPRA, HSA, HZZO, Laegemiddelstyrelsen, LINAME (formulary), Lyfjastofnun lyfjaverdskra, MISPAS, MoH deltio timwn, MZ SR kategorizacia, NEAK PUPHA, NHRA, NHS dm+d VMP, PAMI, PBS, SFDA, SUKL DLP, TFDA, TITCK, URPL RPL; price sources: AIFA liste A/H, CMED, CNS liste positive, DoH SEP database, EDE, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, MoH deltio timwn, MZ SR kategorizacia, NEAK PUPHA, NHRA, PBS, SFDA.
Health Canada Drug Product Database (DPD), DIN 02233653, status date 2007-09-28; national medicine registries: AIFA liste A/H, ALIMS, ANMDMR nomenclator, CBZ, CMED, CNS liste positive, CSG Compendio (formulary), DH Drug Office, DoH SEP database, EDE, eEKO (Erstattungskodex), EMA centrally authorised, EU national register, FDA NDC, FEST (DMP), Fimea Perusrekisteri, HPRA, HSA, HZZO, Laegemiddelstyrelsen, LINAME (formulary), Lyfjastofnun lyfjaverdskra, MISPAS, MoH deltio timwn, MZ SR kategorizacia, NEAK PUPHA, NHRA, NHS dm+d VMP, PAMI, PBS, SFDA, SUKL DLP, TFDA, TITCK, URPL RPL; price sources: AIFA liste A/H, CMED, CNS liste positive, DoH SEP database, EDE, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, MoH deltio timwn, MZ SR kategorizacia, NEAK PUPHA, NHRA, PBS, SFDA. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.